Nicola Principi1, Alberto Zampiero1, Monia Gambino1, Alessia Scala1, Laura Senatore1, Mara Lelii1, Beatrice Ascolese1, Claudio Pelucchi2, Susanna Esposito3. 1. Pediatric Highly Intensive Care Unit, Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. 2. Department of Epidemiology, IRCCS Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy. 3. Pediatric Highly Intensive Care Unit, Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. Electronic address: susanna.esposito@unimi.it.
Abstract
BACKGROUND: Although the incidence of human rhinovirus (HRV) infection is highest in young, no study has yet been published concerning the types of HRV circulating in this population, the incidence of symptomatic infections due to the different types, or duration of shedding OBJECTIVES: This prospective study evaluated the circulation of HRV species and types, and established the incidence of asymptomatic and symptomatic infections in young children. STUDY DESIGN: The study enrolled 93 healthy children aged <2 years, 88 of whom completed the follow-up of weekly household visits from November 2013 to February 2014. At each visit, a record was made of any signs and symptoms of acute infection, and a nasopharyngeal (NP) swab was taken in order to identify the HRVs by means of RT-polymerase chain reaction and to construct the phylogenetic tree of the HRV-positive cases. RESULTS: A total of 1408 NP samples were obtained and 326 HRV infections were diagnosed (23.1%), leading to a mean number of 3.7 ± 2.3 infections per child: HRV-A in 72 cases (22.1%), HRV-B in 29 (8.9%), HRV-C in 122 (37.4%), and non-typeable HRV in 103 (31.6%). Shedding was significantly longer for HRV-A (14 days) and HRV-B (14 days) than HRV-C (7 days; p = 0.002 and p = 0.012). Most of the HRV infections (209/326, 64.1%) remained asymptomatic and, when symptomatic, were of marginal clinical relevance. CONCLUSIONS: In healthy young children, HRV infection is extremely frequent, generally asymptomatic or with a mild clinical presentation, and viral shedding is limited in time.
BACKGROUND: Although the incidence of human rhinovirus (HRV) infection is highest in young, no study has yet been published concerning the types of HRV circulating in this population, the incidence of symptomatic infections due to the different types, or duration of shedding OBJECTIVES: This prospective study evaluated the circulation of HRV species and types, and established the incidence of asymptomatic and symptomatic infections in young children. STUDY DESIGN: The study enrolled 93 healthy children aged <2 years, 88 of whom completed the follow-up of weekly household visits from November 2013 to February 2014. At each visit, a record was made of any signs and symptoms of acute infection, and a nasopharyngeal (NP) swab was taken in order to identify the HRVs by means of RT-polymerase chain reaction and to construct the phylogenetic tree of the HRV-positive cases. RESULTS: A total of 1408 NP samples were obtained and 326 HRV infections were diagnosed (23.1%), leading to a mean number of 3.7 ± 2.3 infections per child: HRV-A in 72 cases (22.1%), HRV-B in 29 (8.9%), HRV-C in 122 (37.4%), and non-typeable HRV in 103 (31.6%). Shedding was significantly longer for HRV-A (14 days) and HRV-B (14 days) than HRV-C (7 days; p = 0.002 and p = 0.012). Most of the HRV infections (209/326, 64.1%) remained asymptomatic and, when symptomatic, were of marginal clinical relevance. CONCLUSIONS: In healthy young children, HRV infection is extremely frequent, generally asymptomatic or with a mild clinical presentation, and viral shedding is limited in time.
Authors: Cibele M Gaido; Shane Stone; Abha Chopra; Wayne R Thomas; Peter N Le Souëf; Belinda J Hales Journal: J Virol Date: 2016-11-14 Impact factor: 5.103
Authors: M E Cole; R Kundu; A F Abdulla; N Andrews; K Hoschler; J Southern; D Jackson; E Miller; M Zambon; P J Turner; J S Tregoning Journal: Clin Exp Immunol Date: 2021-01-13 Impact factor: 5.732
Authors: Timothy Choi; Mark Devries; Leonard B Bacharier; William Busse; Carlos A Camargo; Robyn Cohen; Gregory P Demuri; Michael D Evans; Anne M Fitzpatrick; Peter J Gergen; Kristine Grindle; Rebecca Gruchalla; Tina Hartert; Kohei Hasegawa; Gurjit K Khurana Hershey; Patrick Holt; Kiara Homil; Tuomas Jartti; Meyer Kattan; Carolyn Kercsmar; Haejin Kim; Ingrid A Laing; Petra LeBeau; Kristine E Lee; Peter N Le Souëf; Andrew Liu; David T Mauger; Carole Ober; Tressa Pappas; Shilpa J Patel; Wanda Phipatanakul; Jacqueline Pongracic; Christine Seroogy; Peter D Sly; Christopher Tisler; Ellen R Wald; Robert Wood; Ronald Gangnon; Daniel J Jackson; Robert F Lemanske; James E Gern; Yury A Bochkov Journal: Am J Respir Crit Care Med Date: 2021-04-01 Impact factor: 30.528
Authors: Leigh M Howard; Monika Johnson; Ana I Gil; Marie R Griffin; Kathryn M Edwards; Claudio F Lanata; John V Williams; Carlos G Grijalva Journal: Open Forum Infect Dis Date: 2016-01-13 Impact factor: 3.835
Authors: Cibele M Gaido; Caitlyn Granland; Ingrid A Laing; Peter N Le Souëf; Wayne R Thomas; Andrew J Currie; Belinda J Hales Journal: Immun Inflamm Dis Date: 2017-11-10